These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 38410931)

  • 1. A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs.
    Felsher M; Shumet M; Velicu C; Chen YT; Nowicka K; Marzec M; Skowronek G; Pieniążek I
    Hum Vaccin Immunother; 2024 Dec; 20(1):2319426. PubMed ID: 38410931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV vaccine knowledge, attitude, and programme satisfaction among parents and caregivers of vaccine recipients in Ogun state Nigeria.
    Olubodun T; Ogunsola EA; Coker MO; Olayinka SA; Elegbede WÀ; Ojediran JO; Olajide KB; Sanni SB; Oluwadare TO; Inetagbo OT; Balogun MR; Owolabi OO; Anyadiegwu-Bello CC; Runsewe OA; Temitayo-Oboh AO; Soyannwo T; Ogunsiji OB; Banke-Thomas A
    Reprod Health; 2024 Dec; 21(1):179. PubMed ID: 39633371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key informant perspectives on overcoming HPV vaccination barriers in low-immunization NY counties.
    Hanley SE; Ohri K; Stewart T; Vargas M; Hanley A; Shaw EC; Allis N; Seserman M; Shaw J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2407666. PubMed ID: 39370140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a human papillomavirus vaccination clinical program in a commercially insured population.
    Pelaccio K; Mo M; Olmsted A; DeJager K
    J Manag Care Spec Pharm; 2024 Dec; 30(12):1405-1413. PubMed ID: 39612253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates and determinants of HPV non-vaccination in 14-year-old Canadians: Results from the childhood national immunization coverage survey, 2019.
    Sathiyamoorthy A; Guay M; Chen R
    Hum Vaccin Immunother; 2024 Dec; 20(1):2379090. PubMed ID: 39051527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could oral health care professionals help increase human papillomavirus vaccination rates by engaging patients in discussions?
    Casey SM; Paiva T; Perkins RB; Villa A; Murray EJ
    J Am Dent Assoc; 2023 Jan; 154(1):10-23.e17. PubMed ID: 36503668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult vaccination in India: A rapid review of current status & implementation challenges.
    Bhattacharyya A; Shahabuddin SM
    Indian J Med Res; 2024 Sep&Oct; 160(3&4):279-292. PubMed ID: 39632644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities for HPV vaccine education in school-based immunization programs in British Columbia, Canada: A qualitative study.
    Brohman I; Blank G; Mitchell H; Dubé E; Bettinger JA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2326779. PubMed ID: 38517252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of HPV disease perceptions, vaccine accessibility, and information exposure on social media on HPV vaccination uptake among 11,678 mothers with daughters aged 9-17 years in China: a cross-sectional study.
    Lin Z; Chen S; Su L; Liao Y; Chen H; Hu Z; Chen Z; Fang Y; Liang X; Chen J; Luo B; Wu C; Wang Z
    BMC Med; 2024 Aug; 22(1):328. PubMed ID: 39135035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis.
    Asgedom YS; Kebede TM; Seifu BL; Mare KU; Asmare ZA; Asebe HA; Kase BF; Shibeshi AH; Tebeje TM; Sabo KG; Fente BM; Lombebo AA; Koyira MM; Kassie GA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2326295. PubMed ID: 38505959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia.
    Alghalyini B; Zaidi ARZ; Meo SA; Faroog Z; Rashid M; Alyousef SS; Al-Bargi YY; Albader SA; Alharthi SAA; Almuhanna HA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2403844. PubMed ID: 39377296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study.
    Marfo E; Salami B; Adjei C; MacDonald S
    Hum Vaccin Immunother; 2024 Dec; 20(1):2397219. PubMed ID: 39255822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic literature review on the clinical and economic burden of human papillomavirus-related diseases in select areas in the Asia-Pacific region.
    Lou PJ; Phongsamart W; Sukarom I; Wu YH; Zaidi O; Du F; Simon A; Bernauer M
    Hum Vaccin Immunother; 2024 Dec; 20(1):2425535. PubMed ID: 39552456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Saudi women's awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine.
    Alqarni SS; Alshehri SM; Alkhateeb MA; Alsudias LS
    Hum Vaccin Immunother; 2024 Dec; 20(1):2395086. PubMed ID: 39219415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination.
    Malvi SG; Esmy PO; Muwonge R; Joshi S; Poli URR; Lucas E; Verma Y; Lucksom PG; Shah A; Patel B; Zomawia E; Pimple S; Jayant K; Hingmire S; Chiwate A; Divate U; Vashist S; Mishra G; Jadhav R; Siddiqi M; Sauvaget C; Sankaran S; Kannan TPRA; Shastri SS; Pillai MR; Anantharaman D; Bhatla N; Sankaranarayanan R; Basu P
    J Natl Cancer Inst Monogr; 2024 Nov; 2024(67):317-328. PubMed ID: 39529521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV vaccination intention among guardians of female secondary school students in Chongqing, China.
    Bai N; Wang Q; Shao J; Chen L; Wang C; Xiao X; Yu L; Xu B
    Hum Vaccin Immunother; 2024 Dec; 20(1):2381293. PubMed ID: 39143812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.